{"id":"https://openalex.org/W2186605395","doi":null,"title":"Phase II randomized study of interleukin-2 with or without 13-cis retinoic acid as maintenance therapy in patients with advanced cancer responsive to chemotherapy.","display_name":"Phase II randomized study of interleukin-2 with or without 13-cis retinoic acid as maintenance therapy in patients with advanced cancer responsive to chemotherapy.","publication_year":2005,"publication_date":"2005-07-01","ids":{"openalex":"https://openalex.org/W2186605395","mag":"2186605395","pmid":"https://pubmed.ncbi.nlm.nih.gov/16080579"},"language":"en","primary_location":{"id":"pmid:16080579","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16080579","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063573604","display_name":"F. Recchia","orcid":"https://orcid.org/0000-0002-8428-0112","observed_orcids":["https://orcid.org/0000-0002-8428-0112"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesco Recchia","raw_affiliation_strings":["Unit\u00e0 operativa di Oncologia, Ospedale Civile di Avezzano, Italy. frecchia1946@libero.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit\u00e0 operativa di Oncologia, Ospedale Civile di Avezzano, Italy. frecchia1946@libero.it","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027002636","display_name":"Gaetano Saggio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gaetano Saggio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005705216","display_name":"Alisia Cesta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alisia Cesta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047522068","display_name":"Edoardo Alesse","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edoardo Alesse","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109174129","display_name":"Rita Gallo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rita Gallo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002513524","display_name":"Stefano Necozione","orcid":"https://orcid.org/0000-0003-2501-1665","observed_orcids":["https://orcid.org/0000-0003-2501-1665"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefano Necozione","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5074746794","display_name":"Silvio Rea","orcid":"https://orcid.org/0000-0002-1439-2768","observed_orcids":["https://orcid.org/0000-0002-1439-2768"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Silvio Rea","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7965,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.70772971,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"25","issue":"4","first_page":"3149","last_page":"57"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.7567999958992004,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.7567999958992004,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.11980000138282776,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.020600000396370888,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":1.0},{"id":"https://openalex.org/keywords/isotretinoin","display_name":"isotretinoin","score":0.9829999804496765},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.9670000076293945},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.8460000157356262},{"id":"https://openalex.org/keywords/metastatic-solid-tumors","display_name":"metastatic solid tumors","score":0.8289999961853027},{"id":"https://openalex.org/keywords/cd4-cd8-ratio","display_name":"CD4/CD8 ratio","score":0.8460000157356262},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.9940000176429749},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.9700000286102295},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.6399999856948853},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7039999961853027},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9620000123977661}],"concepts":[{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6436856985092163},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6191133260726929},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.617016077041626},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5970554947853088},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5528421998023987},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.5427257418632507},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5128622055053711},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49504294991493225},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.4611627459526062},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4322962760925293},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.43043771386146545},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.41922345757484436},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36331042647361755},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32517457008361816},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.1450759768486023},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.1062447726726532}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004306","descriptor_name":"Dose-Response Relationship, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015474","descriptor_name":"Isotretinoin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015474","descriptor_name":"Isotretinoin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016516","descriptor_name":"CD4-CD8 Ratio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018655","descriptor_name":"Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:16080579","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16080579","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Clinical Trial"},{"id":"pmh:oai:ricerca.univaq.it:11697/11882","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11697/11882","pdf_url":null,"source":{"id":"https://openalex.org/S7407055225","display_name":"Archivio Istituzionale della Ricerca - Universit\u00e0 degli Studi dell Aquila","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2186605395","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16080579","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W186894364","https://openalex.org/W1574011925","https://openalex.org/W1979011040","https://openalex.org/W1979300931","https://openalex.org/W1983273033","https://openalex.org/W1983467545","https://openalex.org/W1993051112","https://openalex.org/W2037277233","https://openalex.org/W2040005444","https://openalex.org/W2045342915","https://openalex.org/W2049020751","https://openalex.org/W2053164450","https://openalex.org/W2053392008","https://openalex.org/W2086619383","https://openalex.org/W2109539147","https://openalex.org/W2123914905","https://openalex.org/W2162377998","https://openalex.org/W2326245275","https://openalex.org/W2334725998","https://openalex.org/W2335151635","https://openalex.org/W2395033756","https://openalex.org/W2400466234","https://openalex.org/W2413528823","https://openalex.org/W2418779696","https://openalex.org/W2430254743","https://openalex.org/W2435428362","https://openalex.org/W4313333720"],"related_works":["https://openalex.org/W2962785452","https://openalex.org/W2162377998","https://openalex.org/W7216922943","https://openalex.org/W2045342915","https://openalex.org/W7217529743","https://openalex.org/W7217013722","https://openalex.org/W1981174393","https://openalex.org/W1964605790","https://openalex.org/W633263479","https://openalex.org/W2968934906"],"abstract_inverted_index":{"AIM:":[0],"In":[1],"a":[2,28,37,45,61,125,197,265,276],"previous":[3,180],"phase":[4,73],"1B":[5],"study,":[6],"we":[7],"determined":[8],"the":[9,50,80,131,142,167,213,238],"optimal":[10],"biological":[11],"dose":[12],"of":[13,30,40,49,63,71,82,121,176,179,185,200,267,273,278],"interleukin-2":[14],"(IL-2)":[15],"and":[16,56,60,93,146,154,182,188,233,248,275],"13-cis":[17],"retinoic":[18],"acid":[19],"(RA),":[20],"given":[21],"as":[22],"maintenance":[23],"therapy":[24,43],"to":[25,34,78,103,107,212],"patients":[26],"with":[27,36,96,124,210],"variety":[29,266],"solid":[31,268],"tumors,":[32,269],"responding":[33,102],"chemotherapy,":[35,104],"high":[38],"risk":[39],"relapse.":[41],"This":[42],"produced":[44],"statistically":[46,219,228],"significant":[47,221,229,262],"increase":[48,272],"CD4+/CD8+":[51,143,187],"ratio,":[52,144],"natural":[53],"killer":[54],"(NK)":[55],"lymphocyte":[57],"cell":[58],"counts":[59],"decrease":[62,277],"vascular":[64],"endothelial":[65],"growth":[66],"factor":[67],"(VEGF).":[68],"The":[69,160],"aim":[70],"this":[72,85,216],"II":[74],"randomized":[75,106],"study":[76],"was":[77,191,218,226],"verify":[79],"role":[81],"RA":[83,250],"in":[84,193,207,222,231,234,257,264],"drug":[86],"combination.":[87],"PATIENTS":[88],"AND":[89],"METHODS:":[90],"One":[91],"hundred":[92],"twelve":[94],"patients,":[95],"locally":[97],"advanced":[98],"or":[99,130],"metastatic":[100],"tumors":[101],"were":[105,149,163],"receive":[108],"IL-2,":[109],"1.8":[110],"x":[111],"10(6)":[112],"I.U.":[113],"for":[114,117,171],"5":[115],"days/week":[116],"2":[118,152],"consecutive":[119],"cycles":[120],"3":[122],"weeks,":[123],"1-week":[126],"interval":[127],"(arm":[128,139],"A),":[129],"same":[132],"regimen":[133],"plus":[134],"oral":[135,249],"RA,":[136],"0.5":[137],"mg/Kg":[138],"B).":[140],"VEGF,":[141],"NK":[145],"tumor":[147],"markers":[148],"assessed":[150],"every":[151,156],"months":[153],"response":[155],"4":[157],"months.":[158],"RESULTS:":[159],"baseline":[161,183,214],"characteristics":[162],"well":[164],"balanced":[165],"between":[166,237],"two":[168,239],"treatment":[169],"arms":[170,209],"age,":[172],"performance":[173],"status,":[174],"type":[175],"disease,":[177],"amount":[178],"chemotherapy":[181],"values":[184],"NK,":[186],"VEGF.":[189,279],"Toxicity":[190],"minor":[192],"both":[194,208],"arms.":[195,240],"After":[196],"median":[198],"follow-up":[199],"42":[201],"months,":[202],"all":[203,259],"immunological":[204],"parameters":[205,263],"improved":[206],"respect":[211],"values;":[215],"improvement":[217],"more":[220,252],"arm":[223],"B.":[224],"There":[225],"no":[227],"difference":[230],"progression-free":[232],"overall":[235],"survival":[236],"CONCLUSION:":[241],"These":[242],"data":[243],"show":[244],"that":[245],"low-dose":[246],"IL-2":[247,255],"is":[251],"effective":[253],"than":[254],"alone":[256],"improving":[258],"known":[260],"prognostically":[261],"including":[270],"an":[271],"lymphocytes":[274]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}